Root Financial Partners’s Vera Therapeutics VERA Stock Holding History

Root Financial Partners’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$323	Buy	+10	New	+$350	﹤0.01%	3378

Other funds holding VERA

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Root Financial Partners's VERA Position: Q3 2026 in Review

Root Financial Partners opened a new position in Vera Therapeutics (VERA) in Q3 2026: 10 shares worth $323. The stake represents ﹤0.01% of the portfolio and ranks #3378 among its holdings.

147 funds tracked by Wall St. Rank hold VERA as of Q3 2026.

Root Financial Partners held 10 shares of Vera Therapeutics worth $323 as of Q3 2026.
Vera Therapeutics was a new Root Financial Partners position in Q3 2026.
Vera Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3378 holding.
147 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.